Neurotech focusing on the development & commercialisation of neurological solutions
Neurotech International Limited is a medical device and solutions company conducting clinical studies to assess the neuro-protective, anti-inflammatory and neuro-modulatory activities of its proprietary cannabis strains.
Neurotech is listed on the Australian Stock Exchange trades under the ticker symbol “NTI”.
Our first product, Mente Autism, assists with the management of children with Autism Spectrum Disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to help relax the minds of children with ASD. It is simple to use, affordable, is built on clinical grade technology and is effective.
For further information on Mente Autism, please click here.
Neurotech was admitted to the Australian Stock Exchange in November 2016 and trades under the ticker symbol “NTI”. Please access the Investor Centre here for announcements and further information.
